Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel

• 1. 诺孕酯作为TRPC3、TRPC6和TRPC7离子通道选择性抑制剂的用途 [P] . 中国专利： CN101848717B . 2013.09.18
• 2. 诺孕酯作为TRPC3、TRPC6和TRPC7离子通道选择性抑制剂的用途 [P] . 中国专利： CN101848717A . 2010-09-29
• 3. Norgestimate use as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels [P] . BRPI0818823A2 . 2015-04-22

  机译： Norgestimate用作trpc3，trpc6和trpc7离子通道的选择性抑制剂

• 4. Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels [P] . AU2008315952B2 . 2013-09-12

  机译： 使用诺孕酯作为TRPC3，TRPC6和TRPC7离子通道的选择性抑制剂

• 5. USE OF NORGESTIMATE AS A SELECTIVE INHIBITOR OF TRPC3, TRPC6 AND TRPC7 ION CHANNELS [P] . 欧洲知识产权局专利： EP2205247B1 . 2013-07-31

  机译： 使用草甘膦作为TRPC3，TRPC6和TRPC7离子通道的选择性抑制剂

• 1. Store-operated Ca2+ channels formed by TRPC1, TRPC6 and Orai1 and non-store-operated channels formed by TRPC3 are involved in the regulation of NADPH oxidase in HL-60 granulocytes. [J] . Brechard S, Melchior C, Plancon S, Cell Calcium: The International Interdisciplinary Forum for Research on Calcium . 2008,第5期
• 2. Structure of the receptor-activated human TRPC6 and TRPC3 ion channels [J] . Qinglin Tang, Wenjun Guo, Li Zheng, Cell research. . 2018,第7期
• 3. Structure of the receptor-activated human TRPC6 and TRPC3 ion channels [J] . Qinglin Tang, Wenjun Guo, Li Zheng, 细胞研究（英文版） . 2018,第007期
• 4. A Selective and Ultra-Sensitive LC-MS/MS Method for Simultaneous Quantitation of Norgestrel and Norgestimate in Human Plasma [C] . Shuyu Hou, Raj Sheth, Hongkun Liang, ASMS Conference on Mass Spectrometry and Allied Topics . 2016
• 5. M1 muscarinic acetylcholine receptor regulation of endogenous transient receptor potential-canonical, subtype 6 (TRPC6) channels. [D] . Kim, Ju Young. 2005
• 6. Correction for Seo et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy [O] . 2014
• 7. Correction for Seo et al., Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy [O] . 2014

• 1. TRPC3 and TRPC6 Contribute to the Pathogenesis of Hypertension [J] . Qin Zou ,Cui Zhang ,Yuqing Guo . 美国分子生物学期刊（英文） . 2015,第4期
• 2. TRPC3、TRPC6通道与心血管疾病的研究进展 [J] . 谭慧玲 ,赵士弟 . 蚌埠医学院学报 . 2021,第002期
• 3. 去窦弓神经对自发性高血压大鼠主动脉TRPC3及TRPC6表达的影响 [J] . 何杰 ,陈明 . 重庆医科大学学报 . 2012,第12期
• 4. 不同降压药物对自发性高血压大鼠模型左室心肌细胞中TRPC3及TRPC6表达的影响 [J] . 余冬梅 ,陈明 ,廖雪艳 . 岭南心血管病杂志 . 2011,第S1期
• 5. 不同降压药物干预对自发性高血压大鼠主动脉TRPC3及TRPC6表达的影响 [J] . 廖雪艳 ,陈明 ,余冬梅 . 岭南心血管病杂志 . 2011,第S1期
• 6. 血管紧张素Ⅱ通过离子通道蛋白TRPC6诱导足细胞凋亡 [C] . 张涵 ,范青锋 ,刘淑芳 . 2009北京医学会儿科学术年会 . 2009
• 7. 钙离子对TRPC6和TRPC7的相反调节机制 [A] . 史娟 . 2003